Overview

Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Observational study to evaluate the efficacy and safety of meloxicam (Mobicox®) in Mexican population with rheumatic diseases
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Meloxicam